Ayala Pharmaceuticals Inc (ADXS)

[Meishairwin]

Actially, fbg, I think ADXS's terminal value could be north of $6B. My hunch is Dan sees a way to leverage what ADXS has developed across several indications and if there's strong enough science to the first one or two, the next two or three could be relatively quick to FDA approval. Any given cancer indication could be worth $1B-$5B with FDA approval. Do the math.

HOWEVER, this will require significant patience among current shareholders to accept further dilution as part of the fu ding requirement to get there. We're talking ~5yrs, which isn't to say ADXS value won't hit $1B, $2B, etc. along the way. Just made guy not be a straight, even climb.